4.5 Article

Building a population-based diabetes register: An Italian experience

Journal

DIABETES RESEARCH AND CLINICAL PRACTICE
Volume 103, Issue 1, Pages 79-87

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.diabres.2013.11.020

Keywords

Diabetes; Population-based register; Prevalence; Chronic disease management; Record linkage

Funding

  1. Public Health Regional Authority

Ask authors/readers for more resources

Aims: To describe the methodology used to set up the Reggio Emilia (northern Italy) Diabetes Register. The prevalence estimates on December 31st, 2009 are also provided. Methods: The Diabetes Register covers all residents in the Reggio Emilia province. The register was created by deterministic linkage of six routinely collected data sources through a definite algorithm able to ascertain cases and to distinguish type of diabetes and model of care: Hospital Discharge, Drug Dispensation, Biochemistry Laboratory, Disease-specific Exemption, Diabetes Outpatient Clinics, and Mortality databases. Using these data, we estimated crude prevalence on December 31st, 2009 by sex, age groups, and type of diabetes. Results: There were 25,425 ascertained prevalent cases on December 31st, 2009. Drug Dispensation and Exemption databases made the greatest contribution to prevalence. Analyzing overlapping sources, more than 80% of cases were reported by at least two sources. Crude prevalence was 4.8% and 5.9% for the whole population and for people aged 18 years and over, respectively. Males accounted for 53.6%. Type 1 diabetes accounted for 3.8% of cases, while people with Type 2 diabetes were the overriding majority (91.2%), and Diabetes Outpatient Clinics treated 75.4% of people with Type 2 diabetes. Conclusion: The Register is able to quantify the burden of disease, the first step in planning, implementing, and monitoring appropriate interventions. All data sources contributed to completeness and/or accuracy of the Register. Although all cases are identified by deterministic record linkage, manual revision and General Practitioner involvement are still necessary when information is insufficient or conflicting. (C) 2013 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Gastroenterology & Hepatology

The beneficial impact of metabolic dysfunction-associated fatty liver disease on lenvatinib treatment in patients with non-viral hepatocellular carcinoma

Shigeo Shimose, Atsushi Hiraoka, Andrea Casadei-Gardini, Tsubasa Tsutsumi, Dan Nakano, Hideki Iwamoto, Fujimasa Tada, Margherita Rimini, Masatoshi Tanaka, Takuji Torimura, Hideya Suga, Hideko Ohama, Valentina Burgio, Takashi Niizeki, Etsuko Moriyama, Hiroyuki Suzuki, Tomotake Shirono, Yu Noda, Naoki Kamachi, Masahito Nakano, Ryoko Kuromatsu, Hironori Koga, Takumi Kawaguchi

Summary: This study evaluated the impact of MAFLD on the efficacy of lenvatinib in treating HCC. The results showed that MAFLD was a beneficial factor for survival in HCC patients treated with lenvatinib, especially in those with non-viral HCC.

HEPATOLOGY RESEARCH (2023)

Article Environmental Sciences

Association between short-term exposure to air pollutants and cause-specific daily mortality in Italy. A nationwide analysis

Claudio Gariazzo, Matteo Renzi, Alessandro Marinaccio, Paola Michelozzi, Stefania Massari, Camillo Silibello, Giuseppe Carlino, Paolo Giorgi Rossi, Sara Maio, Giovanni Viegi, Massimo Stafoggia

Summary: This study evaluated the association between daily air pollution and cause-specific mortality in 8092 municipalities in Italy. The results showed a positive association between PM10 and PM2.5 and mortality from natural, cardiovascular, cardiac, respiratory, and nervous system causes. NO2 was positively associated with respiratory and metabolic mortality. These findings highlight the potential health hazards of air pollution.

ENVIRONMENTAL RESEARCH (2023)

Article Oncology

Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients

Margherita Rimini, Carles Fabregat-Franco, Mara Persano, Valentina Burgio, Francesca Bergamo, Monica Niger, Mario Scartozzi, Ilario Giovanni Rapposelli, Giuseppe Aprile, Francesca Ratti, Federica Pedica, Helena Verdaguer, Mario Rizzato, Federico Nichetti, Eleonora Lai, Alessandro Cappetta, Teresa Macarulla, Matteo Fassan, Filippo De Braud, Andrea Pretta, Francesca Simionato, Francesco De Cobelli, Luca Aldrighetti, Lorenzo Fornaro, Stefano Cascinu, Andrea Casadei-Gardini

Summary: This study investigated the prognostic impact of IDH1 mutations in patients with advanced iCCA after progression on first-line therapies. The presence of IDH1 mutations was associated with worse overall survival and worse objective response rate in second-line therapy. IDH1 mutations were confirmed as an independent negative prognostic factor.

TARGETED ONCOLOGY (2023)

Article Oncology

Identification of Atezolizumab Plus Bevacizumab Prognostic Index via Recursive Partitioning Analysis in HCC: The ABE Index

Mara Persano, Margherita Rimini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Jaekyung Cheon, Fabian Finkelmeier, Ho Yeong Lim, Jose Presa, Gianluca Masi, Changhoon Yoo, Sara Lonardi, Tiziana Pressiani, Fabio Piscaglia, Takashi Kumada, Lorenza Rimassa, Mario Scartozzi, Stefano Cascinu, Andrea Casadei-Gardini

Summary: This study aimed to establish a novel prognostic index for hepatocellular carcinoma (HCC) patients treated with atezolizumab plus bevacizumab (ABE) in the first-line setting. Using recursive partitioning analysis (RPA), the patients were categorized into high-risk, intermediate-risk, and low-risk groups. The study concluded that the ABE index allows for easy stratification of HCC patients undergoing first-line treatment with ABE.

ANTICANCER RESEARCH (2023)

Article Gastroenterology & Hepatology

Mismatch repair deficiency as prognostic factor for stage III small bowel adenocarcinoma: A multicentric international study

Alessandro Vanoli, Camilla Guerini, Giovanni Arpa, Catherine Klersy, Federica Grillo, Andrea Casadei Gardini, Gert De Hertogh, Marc Ferrante, Annick Moens, Daniela Furlan, Fausto Sessa, Erica Quaquarini, Marco Vincenzo Lenti, Giuseppe Neri, Maria Cristina Macciomei, Matteo Fassan, Stefano Cascinu, Marco Paulli, Rondell Patrell, Antonio Di Sabatino

Summary: This study suggests that mismatch repair deficiency is associated with a better prognosis in stage III small bowel adenocarcinoma (SBA) patients. Testing for mismatch repair status is important for prognostic stratification in these patients.

DIGESTIVE AND LIVER DISEASE (2023)

Article Infectious Diseases

Risk of SARS-CoV-2 reinfection by vaccination status, predominant variant and time from prior infection: a cohort study, Reggio Emilia province, Italy, February 2020 to February 2022

Massimo Vicentini, Francesco Venturelli, Pamela Mancuso, Eufemia Bisaccia, Alessandro Zerbini, Marco Massari, Andrea Cossarizza, Sara De Biasi, Patrizio Pezzotti, Emanuela Bedeschi, Paolo Giorgi Rossi

Summary: This study evaluated the risk of SARS-CoV-2 reinfection based on vaccination status, predominant variant, and time after initial infection. The results showed that two doses of vaccine and prior infection could reduce the risk of reinfection, while natural immunity had low protection against the Omicron BA.1 variant. Combined vaccination and natural immunity were more effective in preventing reinfection than either alone.

EUROSURVEILLANCE (2023)

Review Oncology

Understanding the causes of recurrent HCC after liver resection and radiofrequency ablation

Carlo Bosi, Margherita Rimini, Andrea Casadei-Gardini, Giorgio Ercolani

Summary: Surgical resection and radiofrequency ablation are preferred options for early-stage hepatocellular carcinoma (HCC), and understanding the causes of recurrence and identifying its predictors are priorities in HCC research. Recent insights suggest that vascular invasion and angiogenesis play key roles in HCC recurrence, and agents targeting these hallmarks should be prioritized in early-stage HCC clinical trials. Patient enrollment in clinical trials should also consider the biological characteristics of their inherent disease.

EXPERT REVIEW OF ANTICANCER THERAPY (2023)

Article Gastroenterology & Hepatology

EUS-guided gastroenterostomy for management of malignant gastric outlet obstruction: a prospective cohort study with matched comparison with enteral stenting

Giuseppe Vanella, Giuseppe Dell'Anna, Gabriele Capurso, Patrick Maisonneuve, Michiel Bronswijk, Stefano Crippa, Domenico Tamburrino, Marina Macchini, Giulia Orsi, Andrea Casadei-Gardini, Luca Aldrighetti, Michele Reni, Massimo Falconi, Schalk van der Merwe, Paolo Giorgio Arcidiacono

Summary: This study aimed to report on the clinical outcomes of EUS-GE in a prospective cohort study and compared it with ES. The results showed that EUS-GE demonstrated excellent efficacy in treating mGOO, and had several clinically significant advantages over ES.

GASTROINTESTINAL ENDOSCOPY (2023)

Article Oncology

Survival outcomes from atezolizumab plus bevacizumab versus Lenvatinib in Child Pugh B unresectable hepatocellular carcinoma patients

Margherita Rimini, Mara Persano, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Jaekyung Cheon, Fabian Finkelmeier, Ho Yeong Lim, Jose Presa, Francesca Salani, Sara Lonardi, Fabio Piscaglia, Takashi Kumada, Naoya Sakamoto, Hideki Iwamoto, Tomoko Aoki, Hong Jae Chon, Vera Himmelsbach, Marta Schirripa, Margarida Montes, Caterina Vivaldi, Caterina Solda, Atsushi Hiraoka, Takuya Sho, Takashi Niizeki, Naoshi Nishida, Christoph Steup, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Valentina Burgio, Mario Scartozzi, Stefano Cascinu, Andrea Casadei-Gardini

Summary: This study analyzed the efficacy of atezolizumab plus bevacizumab versus Lenvatinib as first-line treatment for patients with advanced hepatocellular carcinoma (HCC) and Child-Pugh (CP) class B. The results showed that Lenvatinib had a longer overall survival (OS) compared to atezolizumab plus bevacizumab in patients with CP B HCC.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)

Article Public, Environmental & Occupational Health

The Consensus Project: Participation in cervical cancer screening by the first cohorts of girls offered HPV vaccination at age 15-16 years in Italy

Carmen B. Visioli, Paolo Giorgi Rossi, Paola Armaroli, Anna Iossa, Raffaella Rizzolo, Luigina A. Bonelli, Ezio Venturino, Francesca M. Carozzi, Simonetta Bisanzi, Laura De Marco, Livia Giordano, Elisa Camussi, Annarosa Del Mistro, Marco Zappa

Summary: This study evaluated the participation in cervical cancer screening at the age of 25 among girls in Italy who were offered human papillomavirus vaccination at the age of 15 to 16 years. The results showed that vaccinated women had higher participation rates in screening, and active policies targeting the unvaccinated and unscreened population, especially non-native women, are needed to accelerate cervical cancer elimination in Italy.

JOURNAL OF MEDICAL SCREENING (2023)

Article Environmental Sciences

Residential exposure to air pollution and adverse respiratory and allergic outcomes in children and adolescents living in a chipboard industrial area of Northern Italy

Silvia Panunzi, Pierpaolo Marchetti, Massimo Stafoggia, Chiara Badaloni, Nicola Caranci, Kees de Hoogh, Paolo Giorgi Rossi, Linda Guarda, Francesca Locatelli, Marta Ottone, Caterina Silocchi, Paolo Ricci, Alessandro Marcon

Summary: In this cohort study, it was found that exposure to pollutants such as nitrogen dioxide, formaldehyde, and particulate matter is associated with adverse respiratory and allergic outcomes among residents in the Viadana district in northern Italy. These findings highlight the importance of taking preventive measures to improve air quality, particularly targeting emissions from industrial activities.

SCIENCE OF THE TOTAL ENVIRONMENT (2023)

Article Rheumatology

Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases

Luigi Boiardi, Elena Galli, Pierluigi Macchioni, Francesco Muratore, Giulia Klinowski, Gene G. Hunder, Massimiliano Casali, Giulia Besutti, Lucia Spaggiari, Annibale Versari, Stefania Croci, Pamela Mancuso, Paolo Giorgi Rossi, Chiara Marvisi, Carlo Salvarani

Summary: This study compared the clinical and imaging characteristics of Italian patients with Takayasu arteritis (TAK) and large vessel-giant cell arteritis (LV-GCA). The results showed that LV-GCA patients had a higher prevalence of males and more frequently presented with cranial symptoms, fever, polymyalgia rheumatica, and hypertension. TAK patients had longer delay to diagnosis and presented more frequently with loss of pulses of large arteries, vascular bruits, limb claudication, myocardial infarction/angina, and hypertension induced by renal artery stenosis. In terms of treatment, TAK patients received higher doses of prednisone, had longer duration of prednisone therapy, and received traditional immunosuppressants and biological agents more frequently. Flares were more frequent in TAK patients, while no differences were observed for long-term remission. New vascular procedures were more frequently performed in TAK patients. Imaging at diagnosis showed that TAK patients had more frequent vascular stenosis/occlusion and a higher number of vessels with structural damage, while LV-GCA patients had a higher number of inflamed vessels.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2023)

Article Hematology

Effect of Plasma Unit Weight and Donor Sex on Post-Donation Citrate Level: An Experimental Study on Plasmapheresis Donors

Chiara Marraccini, Davide Schiroli, Pamela Mancuso, Giuseppe Molinari, Agnese Razzoli, Gaia Gavioli, Tommaso Fasano, Roberto Baricchi, Paolo Giorgi Rossi, Lucia Merolle

Summary: Plasmapheresis donation is generally safe, but its long-term effects remain unclear. The amount of anticoagulant used in the process varies, and it is influenced by factors such as hematocrit, total blood processed, plasma collected, and donor characteristics. This study found that the unit weight setting and sex have an impact on anticoagulant distribution and post-donation citrate metabolism.

TRANSFUSION MEDICINE AND HEMOTHERAPY (2023)

Article Environmental Sciences

High temperature, COVID-19, and mortality excess in the 2022 summer: a cohort study on data from Italian surveillances

Francesco Venturelli, Pamela Mancuso, Massimo Vicentini, Marta Ottone, Cinzia Storchi, Francesca Roncaglia, Eufemia Bisaccia, Chiara Ferrarini, Patrizio Pezzotti, Paolo Giorgi Rossi

Summary: This study aimed to assess whether the effect of high temperature on mortality differed in COVID-19 survivors and naive individuals. Data from summer mortality and COVID-19 surveillances were used. The results showed a 3.8% excess risk in summer 2022 compared to 2015-2019, with a 20% increase in the last fortnight of July, the period with the highest temperature. The increase in mortality rates during this period was higher among naive individuals compared to COVID-19 survivors. Time series analysis confirmed the association between temperatures and mortality in naive individuals but not in COVID-19 survivors.

SCIENCE OF THE TOTAL ENVIRONMENT (2023)

Article Public, Environmental & Occupational Health

Motivation, acceptability and attitudes toward lung cancer screening among persons who attend a tobacco cessation program: A multicenter survey in Italy

Olivera Djuric, Paolo Giorgi Rossi, Elena Camelia Ivanciu, Salvatore Cardellicchio, Chiara Cresci, Laura Carozzi, Francesco Pistelli, Valentina Bessi, Patrizia Gai, Valentina Galli, Giacomo Lavacchini, Claudia Bricci, Giuseppe Gorini, Sandra Bosi, Eugenio Paci, Working Grp

Summary: This study aimed to assess the motivation to quit smoking and the acceptability of a lung cancer screening program among people attending smoking cessation programs. A survey involving 197 participants was conducted, and questionnaires and information sheets about the benefits and harms of the screening program were distributed during the courses. The majority of participants expressed a favorable perception of the screening program, despite concerns about potential harms.

PREVENTIVE MEDICINE REPORTS (2023)

No Data Available